March 2013 Newsletter

Our newsletter is sent at the beginning of each month and includes upcoming and currently enrolling studies.

If you would like to subscribe please send us a message through our contact form or on facebook

 March Newsletter

If you or someone you know may be interested in one of our currently enrolling studies, or if you have any questions about these studies, please feel free to contact us.  You can contact us by calling one of our locations or through the contact form on our website.  Our staff is available to provide more details about these studies and can answer any questions you may have.  We look forward to hearing from you!

J. Lewis Research is now on Facebook!

Like us on facebook to stay updated on our research studies

View our Centerwatch profile here

Adolescent Migraine – Ages 12 to 17 years

Participating locations: Foothill Family Clinic North and South, Jordan River Family Medicine

Trial of Evaluation and Efficacy of Nasal spray for ZOMIG®

Does your child experience migraine headaches? If the answer to this question is yes, and your child is 12-17 years of age, and experiences two or more migraine headaches a month, he or she may be eligible to join a clinical research study looking at an investigational treatment for migraine headaches.

The study will involve 3-4 visits to our clinic. Your child would be given a nasal spray containing study medication to take when a migraine headache occurs.

Pediatric Allergies – Ages 6 to 11 years

Participating locations: Foothill Family Clinic North and South

Does your child suffer from year-round allergies?  Contact us for more information about a study for pediatric Allergic Rhinitis.

Vaginal Atrophy – Age 40 years and up (postmenopausal)

Participating locations: Foothill Family Clinic North and South

This study is for the treatment of symptoms of vaginal atrophy, including vaginal dryness, in post-menopausal women.  Please call 801-365-1032 (ask for Research at South) or 801-486-3021 (ask for Research at North) for more information.

Hypertension – Ages 18 and up

Participating locations: Foothill Family Clinic North and South

Please call 801-365-1032 (ask for Research at South) or 801-486-3021 (ask for Research at North) for more information.

Dust Mite – Ages 12 and up

Participating locations: Foothill Family Clinic South

Sneezing? Itching? Watery Eyes?

There’s Room for You In Our Research Study

The DynaMite study is testing an investigational immunotherapy tablet for people with dust mite allergy.  You or your child may be eligible to take part if the following criteria are met:

  • 12 years of age or older
  • Have been taking allergy medications for dust mite allergy symptoms during the past year

Medical history and other criteria will be reviewed at the first study visit.  A skin prick allergy test and blood test will also be done.  All study-related office visits, medical examinations, and investigational immunotherapy treatment will be provided at no cost to qualified participants.

If you’re tired of the sneezing, itchy eyes, runny nose and more caused by dust mite allergies, we encourage you to visit the study website to learn more and to see if you qualify for the study.

MMR Vaccine – Ages 12 to 15 months 

Participating locations: Foothill Family Clinic North and South

A clinical research study is evaluating an investigational vaccine to prevent Measles/ Mumps/ Rubella (MMR) in children.

To qualify for this clinical study, your child must be:

  • 12 to 15 months of age
  • Accompanied by a parent or guardian at each study visit
  • Up to date on all current childhood vaccinations

If your child joins this clinical study he/she will receive:

  • MMR vaccinations at no cost
  • Study-related medical check-ups

More about the MMR Vaccine:

The MMR vaccine is a combination vaccine that protects against measles, mumps, and rubella.  The CDC recommends two doses of MMR vaccine for all children: dose 1 at 12-15 months, and dose 2 at ages 4-6 years.

Measles outbreaks can occur in communities with a high number of unvaccinated people.  Maintaining high overall MMR vaccination rates is needed to continue to limit the spread of measles.

For more information about the MMR vaccine, please follow the link:

http://www.cdc.gov/vaccinesafety/Vaccines/MMR/index.html

MMR Vaccine – Ages 4 to 6 years

Participating locations: Jordan River Family Medicine

A clinical research study is evaluating an investigational vaccine to prevent Measles/Mumps/Rubella (MMR) in children

To qualify for this clinical study, your child must be:

  • 4 to 6 years of age
  • Accompanied by a parent or guardian at each study visit
  • Up to date on all current childhood vaccinations

If your child joins this clinical study he/she will receive:

  • MMR vaccination
  • Study-related medical check-ups
  • Payment for the cost of travelling to study visits

Meningitis B Vaccine vs. Havrix – Ages 10 to 25 years

Participating locations: Foothill Family Clinic North and South, Jordan River Family Medicine

What is meningococcal disease type B (MnB)?

  • Meningococcal (men-in-juh-coc-cal) disease, also called meningitis (men-in-jai-tis), is a serious illness
  • It causes the tissues that surround the brain and spinal cord to swell and become inflamed
  • Meningococcal disease is caused by a certain type of bacteria that can make young people (10-25) very sick

Are there different types of meningococcal disease?

  • There are many different types of meningococcal disease
  • You may have already received a vaccine to prevent some types of meningococcal disease
  • There is no vaccine to prevent meningococcal disease type B (MnB)

What can I do today?

  • This office is part of a clinical trial to test an investigational vaccine for MnB
  • This trial is called “MEMENTO 014”

More about Meningococcal disease:

Meningococcal infections can be treated with drugs such as penicillin.  Still, many people who get the disease die from it, and many others are affected for life.  This is why preventing the disease through use of meningococcal vaccine is important for people at high risk.

Meningococcal disease is most common in infants less than one year of age and people 16-21 years.  Other people at increased risk include college freshmen living in dormitories, U.S. military recruits, anyone who has an immune system disorder, and people who might have been exposed to meningitis during an outbreak.

 For more information about the meningococcal vaccine, please follow the link and click on Meningococcal Disease:

http://www.immunize-utah.org/information%20for%20the%20public/immunization%20recommendations/adolescents.html

Meningitis B Vaccine – Ages 10 to 12 years

Participating locations: Foothill Family Clinic North and South and Jordan River Family Medicine

What is meningococcal disease type B (MnB)?

Meningococcal disease type B (MnB) is caused by a certain type of bacteria that can make your child very sick. No vaccine to prevent MnB is currently available.  Your child (ages 10-12) may be eligible to take part in a clinical trial to test an investigational vaccine for MnB.

Birth Control – Ages 18 to 50 years

Participating locations: Foothill Family Clinic North and Jordan River Family Medicine

Seeking a different kind of birth control pill?  Explore your options.

Local doctors are studying a new type of low dose investigational birth control pill. This clinical research study is studying an investigational birth control pill that uses hormones similar to those already in your body. If you’re a sexually active woman between 18 and 50 and qualify for this study, you may receive at no cost:

  • Study birth control medication for a year
  • Study-related care from a local doctor
  • Possible reimbursement for time and travel

Ask your doctor for more information or contact our clinic to see if you may be eligible to participate.

Licensed Hepatitis B Vaccine – Ages 20 years and up

Participating locations: Foothill Family Clinic North

*We are only looking for those with Type 2 diabetes at this point in the study*

Research Study of a Hepatitis B Vaccine in Adults 20 years of age and older with or without Type 2 diabetes

What is this study about? Are you interested? This study will test how the body responds to a hepatitis B vaccine for adults with or without type 2 diabetes.  You may join this study if:

  • You are 20 years of age or older
  • Within the past 5 years, you have had type 2 diabetes OR never had diabetes
  • You have never had a hepatitis B vaccine
  • You have never had hepatitis B infection
  • The study team will tell you what else is needed to join this study

Swimmer’s Ear – Ages 6 months and up 

Participating locations: Foothill Family Clinic South

You don’t have to be a swimmer to get swimmer’s ear.

If you are experiencing pain, itching or swelling of the outer ear, you may have a type of ear infection called acute otitis externa (AOE), also known as swimmer’s ear. While swimmer’s ear is most commonly caused by swimming, it can also occur from the use of hearing aids, headphones (or “ear buds”) and various types of hearing protection.

Local doctors in your area are conducting a research study for effectiveness of investigational antibiotic drops for acute otitis externa (AOE). Individuals 6 months of age or older with swimmer’s ear may be eligible to participate.

Visit the study website for more information: SplashSwimmersEarStudy.com

Celiac Disease – Ages 18 to 75 years

Participating locations: Foothill Family Clinic North

Do you or someone you know have Celiac Disease? Follow a Gluten-free diet? Still experiencing symptoms when exposed to gluten? Interested in Celiac Research?

Alba Therapeutics is sponsoring a clinical trial locally for Celiac Disease. The purpose of the research study is to look at how effective and safe an investigational medication is when it is given to subjects who have celiac disease. The study will include people who have been diagnosed with celiac disease and have been on a gluten-free diet for 12 months or more before study entry.

You may qualify for the study if you:

  • Are between the ages of 18 and 75 and have been diagnosed with celiac disease
  • Have biopsy proven celiac disease and positive serology test results
  • for 12 months or more before study entry
  • Have been on a gluten-free diet for 12 months or more before study entry
  • Are still experiencing symptoms when exposed to gluten
  • Have positive serum anti-tTG (IgA or IgG) or DGP (IgA or IgG) antibodies at screening
  • Are willing to maintain your current diet for the duration of the study